Mutant Dominant-negative Causes Protein Aggregates Degraded Via ERAD and Prevents Normal Rhodopsin from Proper Membrane Trafficking

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2024 Jun 3

PMID 38828393

Authors

Bowen Cao

Johanna Valentina Dahlen

Merve Sen

Tina Beyer

Tobias Leonhard

Ellen Kilger

Blanca Arango-Gonzalez

Marius Ueffing

Affiliations

Soon will be listed here.

Abstract

Dominant mutations in the rhodopsin gene () contribute to 25% of autosomal dominant retinitis pigmentosa (adRP), characterized by photoreceptor loss and progressive blindness. One such mutation, carries a 3-bp deletion, resulting in the loss of one of two isoleucines at codons 255 and 256. Our investigation, using recombinant expression in HEK293 and COS-7 cells, revealed that , akin to the known adRP mutation , induces the formation of rhodopsin protein (RHO) aggregates at the perinuclear region. Co-expression of or with wild-type , mimicking the heterozygous genotype of adRP patients, demonstrated the dominant-negative effect, as all isoforms were retained in perinuclear aggregates, impeding membrane trafficking. In retinal explants from WT mice, mislocalization of labeled adRP isoforms at the outer nuclear layer was observed. Further analysis revealed that RHO aggregates are retained at the endoplasmic reticulum (ER), undergo ER-associated degradation (ERAD), and colocalize with the AAA-ATPase escort chaperone valosin-containing protein (VCP). These aggregates are polyubiquitinated and partially colocalized with the 20S proteasome subunit beta-5 (PSMB5). Pharmacological inhibition of proteasome- or VCP activity increased RHO aggregate size. In summary, RHO exhibits dominant pathogenicity by sequestering normal RHO in ER aggregates, preventing its membrane trafficking and following the ERAD degradation.

References

Sung C, Davenport C, Nathans J . Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J Biol Chem. 1993; 268(35):26645-9. View

Athanasiou D, Aguila M, Bellingham J, Li W, McCulley C, Reeves P . The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res. 2017; 62:1-23. PMC: 5779616. DOI: 10.1016/j.preteyeres.2017.10.002. View

Whorton M, Jastrzebska B, Park P, Fotiadis D, Engel A, Palczewski K . Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem. 2007; 283(7):4387-94. PMC: 2651572. DOI: 10.1074/jbc.M703346200. View

Sakai T, Calderone J, Lewis G, Linberg K, Fisher S, Jacobs G . Cone photoreceptor recovery after experimental detachment and reattachment: an immunocytochemical, morphological, and electrophysiological study. Invest Ophthalmol Vis Sci. 2002; 44(1):416-25. DOI: 10.1167/iovs.02-0633. View

HARGRAVE P . Rhodopsin structure, function, and topography the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2001; 42(1):3-9. View

Gitcho M, Strider J, Carter D, Taylor-Reinwald L, Forman M, Goate A . VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem. 2009; 284(18):12384-98. PMC: 2673306. DOI: 10.1074/jbc.M900992200. View

Mendes H, Cheetham M . Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. Hum Mol Genet. 2008; 17(19):3043-54. DOI: 10.1093/hmg/ddn202. View

Griciuc A, Aron L, Piccoli G, Ueffing M . Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCP. Biochim Biophys Acta. 2010; 1803(3):424-34. DOI: 10.1016/j.bbamcr.2010.01.008. View

Rakoczy E, Kiel C, McKeone R, Stricher F, Serrano L . Analysis of disease-linked rhodopsin mutations based on structure, function, and protein stability calculations. J Mol Biol. 2010; 405(2):584-606. DOI: 10.1016/j.jmb.2010.11.003. View

10.

Mizuno Y, Hori S, Kakizuka A, Okamoto K . Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett. 2003; 343(2):77-80. DOI: 10.1016/s0304-3940(03)00280-5. View

11.

Ye Y, Meyer H, Rapoport T . The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature. 2001; 414(6864):652-6. DOI: 10.1038/414652a. View

12.

Rajan R, Kopito R . Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J Biol Chem. 2004; 280(2):1284-91. DOI: 10.1074/jbc.M406448200. View

13.

Gragg M, Park P . Misfolded rhodopsin mutants display variable aggregation properties. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(9 Pt B):2938-2948. PMC: 6066411. DOI: 10.1016/j.bbadis.2018.06.004. View

14.

Sen M, Kutsyr O, Cao B, Bolz S, Arango-Gonzalez B, Ueffing M . Pharmacological Inhibition of the VCP/Proteasome Axis Rescues Photoreceptor Degeneration in RHO Rat Retinal Explants. Biomolecules. 2021; 11(10). PMC: 8534135. DOI: 10.3390/biom11101528. View

15.

Sen M, Bassetto M, Poulhes F, Zelphati O, Ueffing M, Arango-Gonzalez B . Efficient Ocular Delivery of VCP siRNA via Reverse Magnetofection in RHO P23H Rodent Retina Explants. Pharmaceutics. 2021; 13(2). PMC: 7914601. DOI: 10.3390/pharmaceutics13020225. View

16.

Krebs M, Holden D, Joshi P, Clark 3rd C, Lee A, Kaushal S . Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol. 2009; 395(5):1063-78. DOI: 10.1016/j.jmb.2009.11.015. View

17.

Guerriero C, Brodsky J . The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev. 2012; 92(2):537-76. PMC: 4162396. DOI: 10.1152/physrev.00027.2011. View

18.

Milam A, Li Z, Cideciyan A, Jacobson S . Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1996; 37(5):753-65. View

19.

Li S, Xiao X, Wang P, Guo X, Zhang Q . Mutation spectrum and frequency of the RHO gene in 248 Chinese families with retinitis pigmentosa. Biochem Biophys Res Commun. 2010; 401(1):42-7. DOI: 10.1016/j.bbrc.2010.09.004. View

20.

Artlich A, Horn M, Lorenz B, Bhattacharga S, Gal A . Recurrent 3-bp deletion at codon 255/256 of the rhodopsin gene in a German pedigree with autosomal dominant retinitis pigmentosa. Am J Hum Genet. 1992; 50(4):876-8. PMC: 1682649. View